Showing 1 posts of 1 posts found.
Takeda is threatening to end its partnership with Orexigen to market the obesity drug Contrave, as allegations around its heart …
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
Novogenia breaks ground on personalised healthcare campus
InfectoPharm launches Polish operations with first hospital antibiotic
FibroFind appoints Lee Borthwick as CEO